Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Mancini

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|August 12, 2009
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compoundsPelayo Camps, Xavier Formosa, Carles Galdeano, et al.
Cancer Research|September 12, 2015
Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapyMarsha Pellegrino, Francesca Mancini, Rossella Lucà, et al.
Chemico-Biological Interactions|February 20, 2010
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidatesPelayo Camps, Xavier Formosa, Carles Galdeano, et al.
Hematological Oncology|July 13, 2016
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemiaMarta Chisini, Caterina Stefanizzi, Teresa Ceglie, et al.
Movement Disorders Clinical Practice|April 22, 2026
Sex Differences in Levodopa-Sparing Effect of Safinamide: Post-hoc Findings from a Multicenter, Longitudinal, Case-Control StudyRoberto Cilia, Emanuele Cereda, Fabiana Colucci, et al.
NPJ Vaccines|September 5, 2023
A next-generation GMMA-based vaccine candidate to fight shigellosisOmar Rossi, Francesco Citiulo, Carlo Giannelli, et al.
Chemmedchem|September 23, 2010
Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidatesElisabet Viayna, Tània Gómez, Carles Galdeano, et al.
Journal of Medicinal Chemistry|December 22, 2011
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseasesCarles Galdeano, Elisabet Viayna, Irene Sola, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 27, 2020
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson's disease patientsAngelo Antonini, Giovanni Abbruzzese, Alfredo Berardelli, et al.
Plos One|January 27, 2016
One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17AFrancesca Mancini, Elisabetta Monaci, Giuseppe Lofano, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|August 12, 2009
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compoundsPelayo Camps, Xavier Formosa, Carles Galdeano, et al.
Cancer Research|September 12, 2015
Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapyMarsha Pellegrino, Francesca Mancini, Rossella Lucà, et al.
Chemico-Biological Interactions|February 20, 2010
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidatesPelayo Camps, Xavier Formosa, Carles Galdeano, et al.
Hematological Oncology|July 13, 2016
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemiaMarta Chisini, Caterina Stefanizzi, Teresa Ceglie, et al.
Movement Disorders Clinical Practice|April 22, 2026
Sex Differences in Levodopa-Sparing Effect of Safinamide: Post-hoc Findings from a Multicenter, Longitudinal, Case-Control StudyRoberto Cilia, Emanuele Cereda, Fabiana Colucci, et al.
NPJ Vaccines|September 5, 2023
A next-generation GMMA-based vaccine candidate to fight shigellosisOmar Rossi, Francesco Citiulo, Carlo Giannelli, et al.
Chemmedchem|September 23, 2010
Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidatesElisabet Viayna, Tània Gómez, Carles Galdeano, et al.
Journal of Medicinal Chemistry|December 22, 2011
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseasesCarles Galdeano, Elisabet Viayna, Irene Sola, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 27, 2020
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson's disease patientsAngelo Antonini, Giovanni Abbruzzese, Alfredo Berardelli, et al.
Plos One|January 27, 2016
One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17AFrancesca Mancini, Elisabetta Monaci, Giuseppe Lofano, et al.
Pageof 21